An interesting observation. The shares issued to Bob could be booked to the company at 23.5c which is the closing price yesterday. If that's the case then there could be another revaluation win as per the half year account that had an revenue item -fair gain on financial liability. The fair gain at Dec was the shares to be issued being revalued from 34c to 27c. If they were issued at 23.5c instead of 27.5c, then we would have another gain.
In short, what this means is the shares were issued to Bob for the purchase of the original business at 23.5c. This is a lot better than 34c which was the estimated price at 30/6/18.
Looking for positives with a share price that doesn't seem to reflect what the company is doing.
- Forums
- ASX - By Stock
- SW1
- Ann: Performance Milestone 1 Achieved and Appendix 3B
Ann: Performance Milestone 1 Achieved and Appendix 3B, page-2
-
- There are more pages in this discussion • 8 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add SW1 (ASX) to my watchlist
(20min delay)
|
|||||
Last
1.0¢ |
Change
-0.002(16.7%) |
Mkt cap ! $9.810M |
Open | High | Low | Value | Volume |
1.0¢ | 1.1¢ | 1.0¢ | $10.15K | 1.000M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
5 | 830362 | 0.9¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
1.0¢ | 140143 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 199996 | 0.013 |
2 | 691666 | 0.012 |
1 | 226370 | 0.011 |
1 | 100000 | 0.010 |
1 | 120000 | 0.008 |
Price($) | Vol. | No. |
---|---|---|
0.016 | 531250 | 1 |
0.018 | 462860 | 1 |
0.019 | 1000000 | 1 |
0.020 | 218562 | 1 |
0.021 | 70000 | 1 |
Last trade - 15.48pm 25/11/2024 (20 minute delay) ? |
Featured News
SW1 (ASX) Chart |
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Andy Udell, CCO
Andy Udell
CCO
SPONSORED BY The Market Online